Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neogen (NEOG) EBT Margin: 2010-2025

Historic EBT Margin for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to 20.94%.

  • Neogen's EBT Margin rose 2814.00% to 20.94% in Q3 2025 from the same period last year, while for Aug 2025 it was -121.06%, marking a year-over-year decrease of 11760.00%. This contributed to the annual value of -126.65% for FY2025, which is 12510.00% down from last year.
  • Neogen's EBT Margin amounted to 20.94% in Q3 2025, which was up 107.48% from -279.96% recorded in Q2 2025.
  • In the past 5 years, Neogen's EBT Margin ranged from a high of 20.94% in Q3 2025 and a low of -279.96% during Q2 2025.
  • For the 3-year period, Neogen's EBT Margin averaged around -43.70%, with its median value being -2.54% (2024).
  • Over the last 5 years, Neogen's EBT Margin had its largest YoY gain of 2,814bps in 2025, and its largest YoY loss of 27,726bps in 2025.
  • Over the past 5 years, Neogen's EBT Margin (Quarterly) stood at 9.91% in 2021, then tumbled by 2,473bps to -14.82% in 2022, then skyrocketed by 1,319bps to -1.63% in 2023, then plummeted by 20,445bps to -206.08% in 2024, then skyrocketed by 2,814bps to 20.94% in 2025.
  • Its EBT Margin stands at 20.94% for Q3 2025, versus -279.96% for Q2 2025 and -4.40% for Q1 2025.